(NASDAQ: STAA) Staar Surgical Co's forecast annual revenue growth rate of 15.19% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.81%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.02%.
Staar Surgical Co's revenue in 2026 is $239,442,000.On average, 13 Wall Street analysts forecast STAA's revenue for 2026 to be $15,508,878,369, with the lowest STAA revenue forecast at $13,512,029,202, and the highest STAA revenue forecast at $16,646,681,341. On average, 13 Wall Street analysts forecast STAA's revenue for 2027 to be $16,813,044,178, with the lowest STAA revenue forecast at $14,385,434,094, and the highest STAA revenue forecast at $18,534,107,333.
In 2028, STAA is forecast to generate $18,123,151,516 in revenue, with the lowest revenue forecast at $15,320,729,923 and the highest revenue forecast at $20,811,198,660.